All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21340%2F22%3A00357844" target="_blank" >RIV/68407700:21340/22:00357844 - isvavai.cz</a>

  • Result on the web

    <a href="https://doi.org/10.1186/s41181-022-00161-4" target="_blank" >https://doi.org/10.1186/s41181-022-00161-4</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1186/s41181-022-00161-4" target="_blank" >10.1186/s41181-022-00161-4</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology

  • Original language description

    Background: Recent advances in nanotechnology have ofered new hope for cancer detection, prevention, and treatment. Nanomedicine, a term for the application of nanotechnology in medical and health felds, uses nanoparticles for several applica- tions such as imaging, diagnostic, targeted cancer therapy, drug and gene delivery, tissue engineering, and theranostics. Results: Here, we overview the current state-of-the-art of radiolabeled nanoparticles for molecular imaging and radionuclide therapy. Nanostructured radiopharmaceuticals of technetium-99m, copper-64, lutetium-177, and radium-223 are discussed within the scope of this review article. Conclusion: Nanoradiopharmaceuticals may lead to better development of thera- nostics inspired by ingenious delivery and imaging systems. Cancer nano-theranos- tics have the potential to lead the way to more specifc and individualized cancer treatment. Keywords: Radiolabeled nanoparticles, Technetium-99m, Copper-64, Lutetium-177, Radium-223, Molecular imaging, Radionuclide therapy, Theranostics, Toxicity, Radiopharmacy

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database

  • CEP classification

  • OECD FORD branch

    10402 - Inorganic and nuclear chemistry

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2022

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    EJNMMI Radiopharmacy and Chemistry

  • ISSN

    2365-421X

  • e-ISSN

    2365-421X

  • Volume of the periodical

    7

  • Issue of the periodical within the volume

    04

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    36

  • Pages from-to

    1-36

  • UT code for WoS article

    000787313000001

  • EID of the result in the Scopus database

    2-s2.0-85128850047